My name is Luis Casavantes (known as "DrC" to some of you).
I graduated as a Dermatologist around the time of the introduction of botulinum toxin, hyaluronic acid, lasers and other products and services that revolutionized my medical specialty.
By the turn of the century, I had developed my reputation as a Cosmetic Dermatologist; my practice popularized through my success in treating young individuals with what I believed to be was a mere "premature aging."
I had no idea of the cause of this strange phenomenon until I read a publication from Dr. Andrew Carr (an Australian Infectologist) describing the HIV- associated lipodystrophy syndrome, a terrible epidemic that disfigured faces and bodies in patients under treatment with certain drugs that caused redistribution of the patient's body fat. 
The recognition of this affliction (predominantly known as "facial wasting") quickly became apparent to doctors, patients and the general public. It created a stigma that generated an incredible demand for high-volume soft-tissue fillers that were permanent and more affordable than the temporary alternatives that were being offered with hyaluronic acid (Restylane) or L-polylactic acid (NewFill, now Sculptra).
I found a good alternative: PMMA from Brazil. After an intense training with Dr. Nácul, the developer of the bioplasty technique, I discovered the micro-cannulas and a mechanical injection device for safe and efficient injections of soft tissue fillers. Based on this experience, I developed the "Metered Implant Technology" (MIT) that ensures the mechanical delivery of standard volume and helps to reduce the irregularities of manual injections.
By 2003-2004, my dedicated team and I worked almost seven days a week for two consecutive years, to meet the demand of patients seeking a solution for facial wasting.
I performed thousands of facial reconstructive procedures, attended local, national and international medical meetings as a faculty member. As a result became very proficient in using all types of soft tissue fillers.
My practice continued expanding with patients seeking cosmetic enhancement of their faces and other body areas, penis included.
I performed my first penile girth enhancement treatment using PMMA back in September 2007. I have since personally treated more than 1,500 patients and performed a conservative number of 3,000 girth enhancement procedures. Last year I published a peer-reviewed report of 729 patients in the Journal of Sexual Medicine  with Dr. Gottfried Lemperle (a German Plastic Surgeon, developer of PMMA as a soft tissue filler) and Dr. Palmira Morales (my associate), as co-authors.
Based on the results of our publication, we have a satisfaction rate of 8.7 which is very similar to the reports on facelift surgeries.
We currently offer three different options to our patients: the permanency of PMMA (Metacrill, Linnea), the longevity of CaHA (Radiesse) and PCL (Ellanse), and the reversibility of HA (Belotero, Juvederm). Voluma has been removed from the market in Mexico.
As an avid reader of scientific publications regarding soft tissue fillers, I have realized that most complications and accidents are technique-related (intra-vascular injections with needles, occlusion by pressure, rupture of ducts, and so on). There is no doubt that experience, skill set, and technique ensure safety independently from the nature of the substance injected.
At almost ten years of experience, performing an average of 1.5 procedures per working day and with patients coming from five continents, we are amongst the world leaders in the number of patients treated.
I am pleased to join the Phalloboard forum discussion and help bring clarity to some of the questions asked regarding our distinct and unique phalloplasty procedures. To expedite my responses, my highly skilled nurse of 8 years Wade Zobel, will also be participating to provide the support needed.
Last but not least, I'd like to remind everyone that our participation in this forum is exclusive to discuss only girth enhancement. All personal communication with Avanti Derma must use our dedicated phone lines, email addresses, and website listed below.
1) Carr A, Miller J, Law M, et al. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000;14(3):25-32
2) Casavantes L, Lemperle G, Morales P. Penile Girth Enhancement with PMMA-Based Soft Tissue Fillers. J Sex Med 2016;13:1414-1422.